Related by context. All words. (Click for frequent words.) 74 HIV coinfected 74 relapsed MM 73 myelodysplastic myeloproliferative diseases 73 BARACLUDE ® 72 Castration Resistant Prostate Cancer 71 HBeAg 71 mitoxantrone plus 71 HBeAg positive 70 HBeAg negative chronic hepatitis 70 Oral Fingolimod 70 e antigen HBeAg 69 null responder 69 8mg/kg 69 Xeloda ® 69 Treated Patients 69 Chronic Hepatitis C 69 Peginterferon Alfa 2a 69 Tipranavir 69 HBeAg negative 69 Pharmacokinetics PK 69 fludarabine cyclophosphamide 69 completely resected 69 Meets Primary Endpoint 69 dopamine partial agonist 69 oropharyngeal candidiasis OPC 69 Myelodysplastic Syndrome MDS 69 achieved CCyR 69 chronic eosinophilic leukemia 69 non splenectomized 69 treatment naive genotype 68 alfa 2a 68 recurrent glioblastoma multiforme 68 SPRYCEL ® 68 TO AVOID PREGNANCY WHILE 68 adefovir dipivoxil 68 nucleoside naive 68 Amgen Neulasta R 68 Severe Sepsis 68 Demonstrates Significant 68 Phase 2b Clinical Trial 68 dasatinib Sprycel ® 68 treatment naïve genotype 68 ß blockers 68 Chronic Hepatitis B 68 Peginterferon 68 Posaconazole 68 metastatic malignant 68 Peginterferon alfa 2b 68 Amgen Neulasta ® 68 refractory CLL 68 Complicated Skin 68 Prolongs Survival 68 Mg Uk 67 Adefovir 67 somatostatin analog 67 PegIFN RBV 67 BENICAR HCT 67 infliximab monotherapy 67 HBeAg positive patients 67 ribavirin therapy 67 biologic DMARD 67 essential thrombocythemia ET 67 neutropenia dehydration dyspnea 67 Tigecycline 67 Newly Diagnosed Multiple Myeloma 67 hypereosinophilic syndrome 67 ® lenalidomide 67 stage IIIb IV 67 receiving VELCADE 67 MAGE A3 ASCI 67 Refractory Hodgkin Lymphoma 67 RAPTIVA 67 ritonavir boosted 67 Double Blind Randomized 67 DEB# 67 PEG IFN 67 HBeAg seroconversion 67 KRAS mutant tumors 67 HBeAg negative patients 67 IN PATIENTS WITH 67 Patients Treated With 67 HCV Protease Inhibitor 67 Elitek 67 placebo PBO 67 fluconazole resistant 67 antiretroviral naïve 67 Aptivus ® 67 Adjuvant Treatment 67 Adjunctive Therapy 67 Relapsing Multiple Sclerosis 67 STELARA ® 67 certolizumab 67 CHAMPION PCI 67 Antitumor Activity 67 tipranavir r 67 FUSILEV enhances 67 elevated transaminases 67 nicardipine 67 stage IIIB 67 micafungin 66 beta 1a 66 salmeterol fluticasone 66 ara C 66 decompensated liver disease 66 ug dose 66 Copegus ribavirin 66 advanced hepatocellular carcinoma 66 Pivotal Phase III 66 Nebulized 66 Aflibercept 66 receiving INTRON 66 naïve HCV 66 patients coinfected 66 Parathyroid Hormone 66 Advanced Melanoma 66 Patients Receiving 66 Adjunctive 66 adalimumab Humira 66 Phase IIb Clinical Trial 66 evaluating tivozanib 66 mcg BID 66 emtricitabine tenofovir 66 budesonide pMDI 66 idiopathic membranous nephropathy 66 Lubiprostone 66 TMC# r 66 mild renal insufficiency 66 ALN HPN 66 INSPIRE Trial Phase III 66 Immunotherapeutic 66 rituximab refractory 66 vincristine doxorubicin 66 CIMZIA TM certolizumab pegol 66 PRN FDA Approves 66 SNT-MC#/idebenone 66 Successfully Completes Phase 66 bevacizumab Avastin R 66 Fludara ® 66 PEGINTRON TM 66 ISTODAX ® 66 anthracyclines taxanes 66 gemcitabine cisplatin 66 Diabetic Neuropathy 66 GW# [003] 66 Relapsing Remitting Multiple Sclerosis 66 humanized interleukin 6 66 Mg Usa 66 CCR5 receptor antagonist 66 APTIVUS r 66 ergot derivatives 66 Lymphocytic 66 Renal Cell Carcinoma RCC 66 Systemic Sclerosis 66 patientswith 66 lamivudine refractory patients 66 Pegasys peginterferon alfa 2a 66 efavirenz EFV 66 Flu Cy 66 minimally symptomatic metastatic castrate 66 Ecallantide 66 inhalation powder 66 FDA APPROVES 66 assessing T DM1 66 mRCC 66 Atypical Hemolytic Uremic Syndrome 66 splenectomized patients 66 Fluconazole 66 Relapsed Refractory 66 HoFH 66 abacavir Ziagen 65 Zorbtive TM 65 overactive bladder syndrome 65 ORENCIA ® 65 ribavirin RBV 65 Multiple Myeloma MM 65 Hsp# Inhibitor 65 Raptiva r 65 gemcitabine carboplatin 65 VELCADE melphalan 65 tumors GIST 65 Plaque Psoriasis 65 Retreatment 65 Cutaneous T 65 INVANZ 65 alpha 2a 65 Preclinical Models 65 VP# [004] 65 See WARNINGS 65 triciribine phosphate monohydrate 65 Intravenous immunoglobulin 65 Demonstrates Positive 65 Soft Tissue Sarcoma 65 Interferon alfa 65 #mg #mg #mg [003] 65 Mycophenolate Mofetil 65 AA Amyloidosis 65 invasive aspergillosis 65 GOUT 65 Pegylated Interferon 65 LAB CGRP 65 IFN alfa 65 CIMZIA ™ 65 Tesmilifene 65 reduce serum phosphate 65 docetaxel Taxotere ® 65 LymphoStat B belimumab 65 q#h 65 alpha 2b 65 Decitabine 65 Partial Response 65 Infusion Reactions Severe 65 chronic idiopathic thrombocytopenic purpura 65 Hormone Refractory Prostate Cancer 65 bone marrow reticulin deposition 65 pegylated interferon alpha 2a 65 paroxetine sertraline 65 CANCIDAS 65 oral ridaforolimus 65 galiximab 65 Bosutinib 65 COPEGUS R 65 invasive candidiasis 65 bacillus Calmette Guerin 65 Investigational Oral 65 non nucleoside inhibitor 65 Infected Patients 65 FOLFIRI alone 65 Multiple Ascending Dose 65 #-# Full Text 65 CLL SLL 65 #mg BID [003] 65 receiving prophylactic anticoagulation 65 resistant hormone refractory 65 Kinoid 65 unfractionated heparin UFH 65 develop HBV reactivation 65 refractory chronic lymphocytic 65 vinorelbine tartrate 65 ACTEMRA TM 65 topical gel formulation 65 receptor tyrosine kinase inhibitor 65 Dabigatran etexilate 65 FEMALES SHOULD BE ADVISED 65 acetonide FA 65 Chronic Sinusitis 65 Saquinavir 65 thalidomide Thalomid 65 CAELYX 65 Shows Efficacy 65 Single Dose 65 ertapenem 65 Epivir HBV 65 AZT zidovudine Retrovir 65 Fludarabine 65 RhuDex TM 65 HCV Genotype 65 metastatic GIST 65 severe hypercholesterolemia 65 Adjuvant Chemotherapy 65 Irinotecan 65 Crit Rev 65 PegIFN 65 Lenalidomide 65 liver histology 65 dacarbazine DTIC 65 discontinued Viread 65 abacavir lamivudine 65 interferon gamma 1b 65 CYT# potent vascular disrupting 65 R lenalidomide 65 HCV SPRINT 65 Telithromycin 65 deep venous thromboses 65 AVONEX ® 65 Entecavir 65 #:#-# [031] 65 Initiate Phase 65 posaconazole 65 pegylated interferon alfa 2a 65 Paraplatin ® 64 Antiviral Therapy 64 CONCERTA 64 Investigational Treatment 64 mild hepatic impairment 64 adefovir treated 64 MKC# MT 64 divalproex sodium 64 Nitazoxanide 64 ZACTIMA 64 Copegus ® 64 virus HCV 64 pyrexia mucositis sepsis febrile 64 refractory cutaneous T 64 peginterferon alpha 2a 64 TPV r 64 Virologic 64 RLAI 64 candidemia 64 metastatic colorectal carcinoma 64 Teriflunomide 64 VARIVAX 64 chronic HCV genotype 64 relapsed ALL 64 PEGylated Fab fragment 64 voriconazole 64 See CLINICAL PHARMACOLOGY 64 Linezolid 64 Betaferon R 64 TURBT 64 -#.# log# 64 Romidepsin 64 R adefovir dipivoxil 64 trastuzumab Herceptin ® 64 relapsing multiple sclerosis 64 ZOLINZA 64 CRp 64 glucocorticoid induced osteoporosis 64 Nilotinib 64 piperacillin tazobactam 64 IOP lowering 64 plus DOXIL 64 ADP receptor antagonist 64 Pafuramidine 64 #/#mg 64 LEXIVA r 64 FOR FURTHER INFORMATION ABOUT 64 Previously Treated 64 Stage IIB 64 ARIXTRA R 64 By JENNIFER LEARN 64 Hepatitis C Genotype 64 inhaled treprostinil 64 HBV infections 64 G#DT 64 null responder HCV 64 Novel Oral 64 J Am Coll 64 APTIVUS R 64 Pazopanib 64 seroconverted 64 pegylated interferon alpha 64 Study Evaluating 64 refractory gout 64 peginterferon alfa 64 azilsartan medoxomil 64 Pooled Analysis 64 Ribavirin causes 64 Cariprazine 64 R entecavir 64 lymphocytosis 64 adjunctive placebo 64 Pegloticase 64 Pemetrexed 64 cisplatin gemcitabine 64 lopinavir r 64 DOXIL 64 plus prednisone 64 Metastatic Melanoma 64 dual endothelin receptor antagonist 64 Neurol 64 PREZISTA r 64 using lactulose concomitantly 64 antiretroviral naive 64 Aeolus Pharmaceuticals Announces 64 polycythemia vera essential thrombocythemia 64 plus prednisone prednisolone 64 cyclophosphamide methotrexate 64 DOXIL ® 64 Capecitabine 64 unresectable stage 64 PREZISTA ritonavir 64 histologically confirmed 64 Vicriviroc 64 MCyR 64 oblimersen 64 omega interferon 64 moderate renal impairment 64 Follicular Lymphoma 64 R Saizen R 64 liposomal amphotericin B 64 Novel Compound 64 Initiates Clinical Trial 64 -#.# log# copies mL 64 CIMZIA TM 64 leukopenia pancytopenia thrombocytopenia 64 recurrent genital herpes 64 J Shoulder Elbow 64 Philadelphia Chromosome Positive 64 Initiate Clinical Trial 64 ALT normalization 64 Orally Active 64 APTIVUS 64 Initiates Enrollment 64 Initiates Phase II 64 Granted Orphan Drug 64 miconazole MBT 64 haematological malignancies 64 BUPHENYL R 64 stated Michelle Berrey 64 Naive Patients 64 arsenic trioxide injection 64 DepoCyt 64 chlorambucil 64 insulin glulisine 64 Hepatotoxicity 64 prucalopride 64 miconazole Lauriad ® 64 flutamide 64 placebo dexamethasone 64 Albuferon TM 64 pharmacokinetic PK study 64 Placebo Controlled Trial 64 included exfoliative dermatitis 64 Hycamtin ® 64 Crofelemer budesonide foam 64 pT2 64 elevated LDH 64 Azacitidine 64 cetuximab Erbitux R 64 PROCTOCORT R 64 subcutaneous immunoglobulin 64 Acute Decompensated Heart Failure 64 FluCAM 64 receiving XGEVA 64 Treatment Naive Patients 64 Dementia Related Psychosis 64 Degarelix 64 corticosteroid dose 64 #mg QD [002] 64 Valopicitabine 64 CYP#A# substrate 64 epoetin alpha 64 Protease Inhibitor 64 Doxil ® 64 rALLy 64 Nephrol 64 chronic HBV 64 ErbB2 positive 64 leukemia AML 64 Completes Patient Enrollment 64 metastatic hormone refractory 64 AVAPRO 64 #mg q8h 64 paclitaxel Taxol R 64 Bacteremia 64 rizatriptan 64 biochemical relapse 64 Gleevec Glivec 64 diarrhea predominant irritable 64 headache abdominal pain 64 NMIBC 64 4mg/kg 64 saline placebo 64 Certolizumab pegol 64 Ranolazine 64 herpetic keratitis 63 BUPHENYL 63 oxycodone CR 63 Proc Am Soc 63 labetalol 63 trimethoprim sulfamethoxazole 63 CCX# B 63 erlotinib Tarceva ® 63 BUPHENYL R sodium phenylbutyrate 63 Bezielle 63 Combination REOLYSIN R 63 Navelbine ® 63 basal bolus regimen 63 Maribavir 63 Moxifloxacin 63 anagrelide 63 bisoprolol 63 brivanib 63 Bronchiectasis 63 AMEVIVE 63 concurrent ITP 63 receiving immunosuppressive therapy 63 Acute Bacterial Sinusitis ABS 63 esophageal candidiasis 63 MVA HPV IL2 63 Phase IIb Trial 63 fluoxetine paroxetine 63 undetectable HBV DNA 63 achieved ACR# 63 FDA Approvals 63 Percutaneous Tibial Nerve Stimulation 63 lexidronam injection 63 Clinical Trial Results 63 FluCAM arm 63 SCIg 63 Presents Positive 63 de novo AML 63 post herpetic 63 Sandostatin 63 LANTUS ® 63 novel emulsion formulation 63 refractory NSCLC 63 ritonavir boosted atazanavir 63 SinuNase TM 63 hyperphenylalaninemia HPA due 63 REMINYL ® 63 hepatorenal syndrome 63 Monopril 63 INVEGA ® 63 INFERGEN 63 biliary tract cancer 63 POSIDUR TM 63 J Am Acad 63 CCR5 tropic HIV 63 Achieves Primary Endpoint 63 metastatic malignant melanoma 63 seropositivity 63 receiving highly emetogenic 63 omacetaxine mepesuccinate 63 carbamazepine phenobarbital phenytoin rifampin 63 RhuDex ® 63 metformin XR 63 Peg IFN 63 CTAP# 63 generalized edema 63 visceral metastases 63 pegIFN 63 VISICOL R 63 DDP# 63 plus methotrexate 63 Natalizumab 63 partial remissions 63 unfavorable cytogenetics 63 Oropharyngeal Candidiasis 63 CLARITY study 63 vidofludimus 63 Trastuzumab 63 interferon ribavirin 63 Kepivance 63 memantine HCl 63 #mg/m# [001] 63 Thal Dex 63 Improved Survival 63 Diffuse Large B 63 mg TID 63 Neoadjuvant 63 investigational oral hepatitis C 63 Demonstrated Significant 63 Atomoxetine 63 Phase IIa Clinical Trial 63 STELARA TM 63 Cyclophosphamide 63 Demonstrates Potent 63 investigational antibiotic 63 Submits NDA 63 mL/min/#.# m 2 63 Tumor Response 63 sitaxsentan 63 Ziprasidone 63 REYATAZ R 63 Treatment Experienced 63 Interferon beta 1a 63 CALGB # [002] 63 Clindamycin 63 vaginal candidiasis 63 immunomodulatory therapy 63 Phase 2a Trial 63 FASLODEX 63 PEGylated anti 63 Epratuzumab 63 nucleoside analog 63 plus dexamethasone 63 oral nucleoside analogue 63 cystic fibrosis bronchiectasis 63 HLA A2 63 plasma kallikrein inhibitor 63 estramustine 63 Cethromycin 63 Dose Ranging Study 63 Recurrent Glioblastoma 63 Matrix Phase 2b 63 cell lymphoma CTCL 63 thromboembolic complications 63 complete cytogenetic response 63 PEG INTRON R 63 MetroGel 63 abacavir sulfate lamivudine 63 Fondaparinux 63 doxorubicin cyclophosphamide 63 Artesunate 63 imatinib Gleevec ® 63 REVLIMID ® 63 toenail onychomycosis 63 ALT elevations 63 IMiDs ® compound 63 Raptiva ® 63 linaclotide treated 63 SGPT 63 BENICAR 63 oral beclomethasone dipropionate 63 Median PFS 63 pediatric acute lymphoblastic 63 terfenadine 63 phase III isavuconazole 63 r hGH 63 UPLYSO 63 adriamycin 63 CYP#A# CYP#D# 63 mGluR5 NAM 63 Demonstrate Significant 63 macrolide antibiotic 63 bendamustine 63 grade squamous intraepithelial 63 genotype 1b 63 Squamous 63 pan histone deacetylase 63 IMiDs ® 63 INTEGRILIN R 63 Demonstrates Efficacy 63 EDEMA3 63 coinfected patients 63 candesartan cilexetil 63 Viral Load 63 TAXOTERE R 63 Improves Survival 63 Clevudine 63 Allogeneic 63 LymphoStat B TM 63 sorafenib tablets 63 allogeneic hematopoietic stem cell 63 unresectable HCC 63 Certolizumab 63 dalteparin 63 metastatic castration resistant 63 EOquin TM 63 plus OBT 63 subcutaneously administered 63 Transdermal Patch 63 novel VDA molecule 63 TNF Tumor Necrosis Factor 63 Darinaparsin 63 J Foot Ankle 63 Hypotension 63 rabeprazole 63 Videx Videx EC 63 Is Well Tolerated 63 ORENCIA R 63 RENAL 63 antibody MAb 63 trastuzumab Herceptin R 63 COLAZAL R 63 pegylated alpha interferon 63 Intracerebral 63 Emtriva Viread 63 Fast Track Status 63 pioglitazone HCl 63 Diabetic Foot Ulcer 63 simplex virus 63 Vitrasert R 63 plus COPEGUS 63 Acetate Rectal Suppositories 63 NSABP B 63 relapsed CLL 63 myocardial infarction ventricular fibrillation 63 icatibant 63 cyclophosphamide chemotherapy 63 Protease Inhibitors 63 neutropenic sepsis 63 imipramine Tofranil 63 indinavir Crixivan 63 q8h 63 Pegasys ® 62 forodesine 62 desvenlafaxine succinate 62 Begins Dosing 62 COLAZAL ® 62 Tarceva TM 62 ® bortezomib 62 Progressive Multifocal Leukoencephalopathy 62 unresectable tumors 62 rilonacept 62 Sustiva efavirenz 62 Simulect 62 sorafenib Nexavar 62 Sapacitabine 62 DAS# CRP 62 Ketorolac 62 Improves Outcomes 62 Itraconazole 62 CIMZIA R 62 HER2 Positive Breast Cancer 62 Intravitreal 62 Cloretazine 62 etanercept Enbrel 62 combination antiretroviral therapy 62 Nucleoside 62 genotype 1a 62 penicillin G benzathine 62 μg dose 62 benazepril 62 E1 INT TM 62 Phase 2b Trial 62 FIRMAGON 62 Tyrosine Kinase Inhibitor 62 hematological parameters 62 tolterodine ER 62 Demonstrates Sustained 62 J Clin 62 Bilive 62 HMG CoA reductase inhibitors 62 Engerix B 62 CsA 62 monoclonal antibody conjugated 62 tinidazole 62 fosamprenavir 62 genotypic resistance 62 Kinase Inhibitor 62 KRAS mutations occur 62 systemic invasive fungal 62 Daptomycin 62 palifermin 62 Intra arterial 62 clodronate 62 acute mania 62 Hydrochlorothiazide Tablets 62 Anti Tumor Activity 62 pediatric Crohn disease 62 Beclomethasone 62 sunitinib Sutent ® 62 relapsed refractory AML 62 fluticasone salmeterol 62 Azmacort R 62 Chronic Renal Failure 62 mecasermin 62 recurrent GBM 62 metastatic neuroendocrine tumors 62 vapreotide acetate 62 MGd 62 microgram kg 62 relapsed Acute Myeloid 62 nadolol 62 lopinavir r arm 62 amisulpride 62 Lupus Nephritis 62 seronegative 62 pan HDAC inhibitor 62 cytomegalovirus infection 62 pT3 62 Antiplatelet 62 Apidra ® 62 induce orthostatic hypotension 62 Humanized Anti 62 LHRH receptor positive 62 COPEGUS ribavirin 62 Elderly Patients 62 cutaneous T 62 HuMax 62 Acute Myeloid Leukaemia AML 62 fluvastatin 62 FDA Okays 62 mCRC patients 62 plasma pharmacokinetics 62 interferon alfa 2b 62 Patients Treated 62 pegylated liposomal doxorubicin 62 cytidine nucleoside analog 62 adult chronic ITP 62 immunocompetent patients 62 papillary renal cell carcinoma 62 hemorrhagic cystitis 62 severe renal impairment 62 CTAP# Capsules 62 EGFR mutation positive 62 calcineurin inhibitor 62 smoldering multiple myeloma 62 Zidovudine Tablets 62 Well Tolerated 62 #mg dose [002] 62 Epivir R 62 non resectable 62 β blocker 62 Renal Impairment 62 CR CRu 62 MVA MUC1 IL2 62 IFN α 62 COPEGUS therapy 62 Pulmonary Arterial Hypertension PAH 62 REYATAZ ® 62 oral Hycamtin 62 argatroban 62 RELOVAIR ™ 62 Trimethoprim 62 NRTI resistance 62 Systemic Lupus Erythematosus SLE 62 II Clinical Trial 62 IND Application 62 Acute Renal Failure 62 mesalamine granules 62 achieved sustained virological 62 #.#mg/dL 62 trivalent inactivated vaccine 62 Pneumocystis carinii pneumonia 62 lenalidomide dexamethasone 62 antithymocyte globulin 62 cardiovascular calcification 62 APTIVUS ritonavir 62 MADRS score 62 Adjuvant chemotherapy 62 Curr Opin 62 5q MDS 62 dextromethorphan quinidine 62 Melphalan 62 non CF bronchiectasis 62 Cimzia TM 62 Phase 2b Study 62 PLX STROKE targeting 62 gastrointestinal stromal tumors GIST 62 C1 INH deficiency 62 Teva Provides Update 62 relapsing remitting MS RRMS 62 hypertrichosis occurred 62 sunitinib Sutent 62 Trial Evaluating 62 dose melphalan 62 tipranavir ritonavir 62 RhuDex R 62 K ras mutations 62 ULORIC 62 comparator arm 62 Fingolimod 62 relapsed acute myelogenous 62 Initiates Phase 2b 62 HIV uninfected 62 mg p = 62 Alkeran 62 ALT elevation 62 Neurosurg 62 protease inhibitor PI 62 mcg QD 62 immunomodulatory agents 62 Polymerase Inhibitor 62 peripheral arterial occlusive disease 62 Telintra 62 antidiabetic drug 62 Int J Radiat Oncol 62 Potent Antiviral Activity 62 demonstrated antitumor activity 62 Platinol ® 62 atherosclerotic renal artery stenosis 62 denileukin diftitox 62 baseline LDH 62 5 fluorouracil leucovorin 62 Cilostazol 62 relapsed refractory multiple myeloma 62 Zavesca R 62 riociguat 62 Leukemias 62 recurrent glioma 62 haematologic malignancies 62 HeFH 62 mCRPC 62 familial amyloidotic polyneuropathy FAP 62 Golimumab 62 XYZAL R 62 CR nPR 62 del 5q MDS 62 Tacrolimus 62 peginterferon alfa 2a Pegasys 62 cefazolin 62 NS5B polymerase 62 TMP SMX 62 alefacept 62 mcg kg REBETOL 62 uremic pruritus 62 Dacogen decitabine 62 Immunosuppressant 62 CLINICAL STUDIES 62 Initiates Phase III 62 fluoropyrimidine 62 pamidronate 62 oral prednisolone 62 Statistically Significant 62 TOPAMAX R 62 Pfizer Camptosar 62 J Am Soc 62 atazanavir ritonavir 62 Ixempra 62 nonmetastatic 62 Temodar ® 62 Shows Promise Against 62 small molecule thrombopoietin 62 cinacalcet 62 elvucitabine 62 Tezampanel 62 Acute Exacerbations 62 Treating Chronic 62 Phase Ib Clinical Trial 62 follicular lymphomas 62 eosinophilic asthma 62 darunavir r 62 systemic hypotension 62 dose escalation phase 62 Deferiprone 62 lumiliximab 62 hepatoma 62 NAVISTAR R 62 Mylan Receives Approval 62 caspofungin 62 therapeutically inactive prodrug 62 AGILECT R 62 Lamotrigine 62 IRESSA 62 formerly LymphoStat B 62 RISPERDAL ® 62 T1c 62 Initiates Clinical 62 lenalidomide Revlimid R 62 ceftazidime 62 golimumab CNTO 62 Noxafil 62 Recombinant Human 62 brand ciclesonide HFA 62 MOVIPREP R 62 goserelin 62 chemoradiation therapy 62 DOXIL R 62 Integrase Inhibitor 62 Romiplostim 62 Advanced Colorectal Cancer 62 VIIBRYD 62 intradermal injections 62 Paclitaxel Carboplatin 62 VANTAS ® 62 Pegasys plus Copegus 62 ANDA Filing 62 meropenem 62 ALT flares 62 Antitumor 62 known sulfonamide allergy 62 bladder carcinoma 62 retinal vein occlusion induced 62 Glioblastoma Multiforme 62 mg kg BID 62 Fibrillex TM 62 angioneurotic edema 62 mycophenolate mofetil MMF 62 Subgroup Analysis 62 Glatiramer Acetate 62 ARB telmisartan 62 3TC lamivudine 62 ACE Inhibitors 62 Acute Attacks 62 Chemoradiation 62 perioperatively 62 Platinol ® cisplatin 62 nonnucleoside reverse transcriptase inhibitors 62 post herpetic neuralgia PHN 62 dexamethasone Decadron 62 Traficet EN 62 metastatic gastric 62 Aliskiren 62 FS Antihemophilic Factor Recombinant 62 ARCALYST 62 naive HCV 62 metastatic renal cell carcinoma 62 REYATAZ r arm 62 Treatment Naive HIV 62 fosbretabulin 62 YONDELIS 62 melphalan prednisone 62 imipenem 62 EDEMA3 trial 62 ARCOXIA 62 panitumumab Vectibix R 62 Pegylated interferon 62 ANN INTERN MED 62 Randomized Clinical Trials 62 Alemtuzumab 62 Interferon Beta 62 gemifloxacin 62 boosted protease inhibitor 62 EURIDIS 62 irreversible inhibitor 62 Late Breaker 62 Antifungal 61 mg dosed twice 61 Novel Inhibitor 61 highly emetogenic 61 Myelofibrosis 61 itraconazole Sporanox 61 rasagiline tablets 61 methotrexate monotherapy 61 alkylating agent 61 Treatment Naïve 61 dose escalation clinical 61 aripiprazole Abilify 61 Virulizin ® 61 Voreloxin 61 orally administered inhibitor 61 pancreatic insufficiency 61 Randomized Double blind 61 treat benign prostatic 61 J Cataract Refract 61 oral antidiabetic medication